PBCAR20A

· Precision BioSciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PBCAR20A, covering 2023-01-31 to 2023-01-31. Get the full timeline:

Most recent: Clinical Trial Update: Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL [Phase 1, Phase 2]